Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Inborn Errors of Metabolism

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Re: Pegvaliase Treatment for Adolescents With Phenylketonuria: A Multi-Site Study.

JIMD reports·2026

Same author

Characterizing SMN1 hybrid and deletion alleles using large-scale SNP array-based SMA carrier screening.

BMC medical genomics·2026

Same author

Analysis of purines and pyrimidines across biospecimens: influence of storage temperature and duration.

Scientific reports·2026

Same author

Expert Recommendations for Rapid Response to Positive Newborn Screen for Infantile Krabbe Disease.

Neurology. Genetics·2026

Same author

<i>COASY</i>-Associated Disorders as a Differential Diagnosis in Cases with Newborn Screening Results Suggestive of CPT-I.

International journal of neonatal screening·2026

Same author

Hemoglobin alpha-like subunit mu is expressed during ontogeny and is elevated in alpha thalassemia.

Blood. Red cells & iron·2026

Search research articles

Related Experiment Video

Updated: Apr 14, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

Newborn screening for lysosomal storage disorders.

Dietrich Matern¹, Dimitar Gavrilov², Devin Oglesbee²

¹Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN, USA; Department of Medical Genetics, Mayo Clinic College of Medicine, Rochester, MN; Department of Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, MN.

Seminars in Perinatology

|April 21, 2015

Summary

Newborn screening in the U.S. now includes tests for over 29 disorders. This review covers the current status of newborn screening for lysosomal storage disorders, including Pompe, Fabry, and Gaucher diseases.

Keywords:

Dried blood spots Immunoquantification Lysosomal storage disorders Newborn screening Tandem mass spectrometry

More Related Videos

Quantification of Endosome and Lysosome Motilities in Cultured Neurons Using Fluorescent Probes

Quantification of Endosome and Lysosome Motilities in Cultured Neurons Using Fluorescent Probes

Published on: May 22, 2017

Characterization of Neuronal Lysosome Interactome with Proximity Labeling Proteomics

Characterization of Neuronal Lysosome Interactome with Proximity Labeling Proteomics

Published on: June 23, 2022

Related Experiment Videos

Last Updated: Apr 14, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

Quantification of Endosome and Lysosome Motilities in Cultured Neurons Using Fluorescent Probes

Quantification of Endosome and Lysosome Motilities in Cultured Neurons Using Fluorescent Probes

Published on: May 22, 2017

Characterization of Neuronal Lysosome Interactome with Proximity Labeling Proteomics

Characterization of Neuronal Lysosome Interactome with Proximity Labeling Proteomics

Published on: June 23, 2022

Area of Science:

Biochemistry
Genetics
Public Health

Background:

Newborn screening is crucial for early detection of genetic disorders.
Advancements in screening technology enable the identification of more conditions.
Lysosomal storage disorders (LSDs) are increasingly considered for inclusion in newborn screening.

Purpose of the Study:

To review the current state of newborn screening for specific lysosomal storage disorders.
To discuss the feasibility and benefits of including LSDs in newborn screening programs.

Main Methods:

Literature review of current newborn screening practices.
Analysis of pilot studies and existing international screening programs for LSDs.

Main Results:

Several LSDs, including Pompe disease, Fabry disease, and Gaucher disease, have been evaluated for newborn screening.
Some LSDs are already part of select national or international newborn screening panels.
Evidence supports the early detection and potential benefit of screening for these conditions.

Conclusions:

Newborn screening programs are expanding to include more lysosomal storage disorders.
Early detection of LSDs through newborn screening can lead to timely intervention and improved outcomes.
Continued evaluation and implementation of LSD screening are warranted.